ATE439866T1 - Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex - Google Patents

Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex

Info

Publication number
ATE439866T1
ATE439866T1 AT06727994T AT06727994T ATE439866T1 AT E439866 T1 ATE439866 T1 AT E439866T1 AT 06727994 T AT06727994 T AT 06727994T AT 06727994 T AT06727994 T AT 06727994T AT E439866 T1 ATE439866 T1 AT E439866T1
Authority
AT
Austria
Prior art keywords
cest
contrast agents
magnetic resonance
resonance imaging
paramagnetic complex
Prior art date
Application number
AT06727994T
Other languages
English (en)
Inventor
Nicolaas Willard
Rene Wegh
Jeroen Pikkemaat
Holger Gruell
Original Assignee
Koninkl Philips Electronics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninkl Philips Electronics Nv filed Critical Koninkl Philips Electronics Nv
Application granted granted Critical
Publication of ATE439866T1 publication Critical patent/ATE439866T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
AT06727994T 2005-04-26 2006-04-21 Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex ATE439866T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103356 2005-04-26
PCT/IB2006/051235 WO2006114738A2 (en) 2005-04-26 2006-04-21 Mri contrast agents comprising cest active paramagnetic complex

Publications (1)

Publication Number Publication Date
ATE439866T1 true ATE439866T1 (de) 2009-09-15

Family

ID=37215130

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06727994T ATE439866T1 (de) 2005-04-26 2006-04-21 Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex

Country Status (7)

Country Link
US (1) US8734761B2 (de)
EP (1) EP1881852B1 (de)
JP (1) JP5638752B2 (de)
CN (1) CN101166547B (de)
AT (1) ATE439866T1 (de)
DE (1) DE602006008604D1 (de)
WO (1) WO2006114738A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070292354A1 (en) * 2004-09-23 2007-12-20 Guerbet Contrast Agents Encapsulating Systems for Cest Imaging
JP5271077B2 (ja) * 2005-04-26 2013-08-21 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 時間変調されたコントラストの向上を備えた造影剤を伴うｍｒｉ
EP2065058A1 (de) * 2007-11-28 2009-06-03 Koninklijke Philips Electronics N.V. Nicht kugelförmige Kontrastmittel für CEST-MRI auf der Basis des magnetischen Bulk-Suszeptibilitätseffekts
WO2010040117A2 (en) 2008-10-03 2010-04-08 California Institute Of Technology Extraction of anions from solutions and mixtures using hyperbranched macromolecules
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
US9289505B2 (en) 2010-08-17 2016-03-22 Rutgers, The State University Of New Jersey Compositions and methods for delivering nucleic acid molecules and treating cancer
JP5802680B2 (ja) * 2010-11-26 2015-10-28 国立大学法人九州大学 常磁性を有する水溶性ハイパーブランチポリマー
JP6092121B2 (ja) * 2011-01-09 2017-03-08 エイエヌピー テクノロジーズ， インコーポレイテッド 疎水性分子に誘起された分岐ポリマー凝集体及びその使用
US11931740B2 (en) 2012-02-13 2024-03-19 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US11485968B2 (en) 2012-02-13 2022-11-01 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US9604213B2 (en) 2012-02-13 2017-03-28 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US9637775B2 (en) 2012-02-13 2017-05-02 Neumodx Molecular, Inc. System and method for processing biological samples
CN114134029A (zh) 2012-02-13 2022-03-04 纽莫德克斯莫勒库拉尔公司 用于处理和检测核酸的微流体盒
ES2741749T3 (es) 2012-10-25 2020-02-12 Neumodx Molecular Inc Método y materiales para el aislamiento de materiales de ácido nucleico
JP6297440B2 (ja) * 2013-07-31 2018-03-20 キヤノンメディカルシステムズ株式会社 造影剤
JP6411117B2 (ja) 2013-07-31 2018-10-24 キヤノンメディカルシステムズ株式会社 医用画像診断装置及び超音波診断装置
CN104623697B (zh) * 2015-02-08 2017-03-22 中国科学院武汉物理与数学研究所 一种基于人体生理温度响应的聚合物胶束型磁共振造影剂的制备方法
US9890187B2 (en) 2015-06-26 2018-02-13 Epos-Iasis Research And Development, Ltd. Prototype systems of theranostic biomarkers for in vivo molecular management of cancer
CN108369266B (zh) * 2015-12-23 2021-08-06 伯拉考成像股份公司 比率计量的脉冲cest成像
US11353533B2 (en) 2016-02-24 2022-06-07 Ohio State Innovation Foundation Methods and devices for contrast agent magnetic resonance imaging
CN105963718A (zh) * 2016-04-28 2016-09-28 东华大学 一种麦芽糖修饰的钆基螯合物mr造影剂的制备方法
WO2018053460A1 (en) * 2016-09-19 2018-03-22 The Regents Of The University Of California Paramagnetic polymers
CA3044877A1 (en) * 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CN108743977B (zh) * 2018-04-03 2021-03-02 中国科学院武汉物理与数学研究所 一种无重金属离子卟啉化合物造影剂及其在磁共振成像中的应用
CA3098492A1 (en) * 2018-04-27 2019-12-19 University Of Iowa Research Foundation Compositions for chelating metals at low temperatures

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US19878A (en) 1858-04-06 Improvement in plows
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US6746662B1 (en) 1999-02-09 2004-06-08 Board Of Regents The University Of Texas System pH sensitive MRI contrast agents
WO2000047111A1 (en) 1999-02-09 2000-08-17 Board Of Regents The University Of Texas System Ph sensitive mri contrast agents
WO2000066180A2 (en) 1999-04-21 2000-11-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Method for enhancing contrast produced by mri
WO2002030473A1 (en) * 2000-10-11 2002-04-18 Targesome, Inc. Targeted therapeutic agents
WO2002043775A2 (en) * 2000-11-20 2002-06-06 GODFREY, Cullen, M. Paramagnetic metal ion-based macrocyclic contrast agents
DE10135355C1 (de) 2001-07-20 2003-04-17 Schering Ag Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
DE10135356C1 (de) 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
WO2003049604A2 (en) 2001-12-13 2003-06-19 The Johns Hopkins University School Of Medicine Method for mr/nmr imaging
EP1331012A1 (de) 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
JP4355144B2 (ja) 2003-01-21 2009-10-28 学校法人日本大学 新規含窒素環状化合物
EP1466629A1 (de) 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducte zwischen NMR Vershibungsreagenzen und Substraten mit austauschbaren Protonen für die "CEST" Anwendung
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
US20070292354A1 (en) * 2004-09-23 2007-12-20 Guerbet Contrast Agents Encapsulating Systems for Cest Imaging

Also Published As

Publication number Publication date
JP5638752B2 (ja) 2014-12-10
CN101166547A (zh) 2008-04-23
WO2006114738A2 (en) 2006-11-02
JP2008539223A (ja) 2008-11-13
WO2006114738A3 (en) 2007-06-21
CN101166547B (zh) 2013-02-06
EP1881852A2 (de) 2008-01-30
DE602006008604D1 (de) 2009-10-01
US20080193384A1 (en) 2008-08-14
EP1881852B1 (de) 2009-08-19
US8734761B2 (en) 2014-05-27

Similar Documents

Publication Publication Date Title
ATE439866T1 (de) Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex
Choi et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets
Gallagher et al. Production of hyperpolarized [1, 4-13C2] malate from [1, 4-13C2] fumarate is a marker of cell necrosis and treatment response in tumors
Sekino et al. Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patients
Singh et al. On B1 inhomogeneity correction of in vivo human brain glutamate chemical exchange saturation transfer contrast at 7T
Witney et al. Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C] pyruvate and [1, 4-13C2] fumarate
Imai et al. Effects on rat testis of 1.95-GHz W-CDMA for IMT-2000 cellular phones
Jeong et al. Real-time quantitative analysis of metabolic flux in live cells using a hyperpolarized micromagnetic resonance spectrometer
Albatany et al. Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla
ATE519505T1 (de) Reaktive paramagnetische kontrastmittel für magnetresonanzbildgebung
Huang et al. Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles
Park et al. p21WAF1 is required for interleukin-16-induced migration and invasion of vascular smooth muscle cells via the p38MAPK/Sp-1/MMP-9 pathway
Lim et al. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy
Kuwahata et al. Development of magnetic probe for sentinel lymph node detection in laparoscopic navigation for gastric cancer patients
ATE421145T1 (de) Aktive abschirmung für eine schaltung mit magnetisch empfindlichen materialien
Cai et al. Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning
Liu et al. MagA expression attenuates iron export activity in undifferentiated multipotent P19 cells
Hoque Bhuiyan et al. Feasibility of diffusion weighting with a local inside‐out nonlinear gradient coil for prostate MRI
Garanger et al. A DNA-binding Gd chelate for the detection of cell death by MRI
ATE410702T1 (de) Testobjekt für kernspintomographen
GB0517077D0 (en) Imaging agent
WO2014165719A1 (en) Non-invasive imaging of tissue redox state by mri
Ganie et al. Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy
Vourganti et al. MR/US fusion technology: what makes it tick?
Karaman et al. Primary melanoma of the male urethra

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties